2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40577 | TAK1-IN-3 | MAPK | |
TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer. | |||
T77084 | Mezagitamab | ||
Mezagitamab (TAK-079), an IgG1λ anti-CD38 monoclonal antibody, functions by depleting tumor cells that express CD38 through both antibody and complement-dependent cytotoxicity. It shows potential for use in the treatment... |